发明名称 Formas cristalinas de 3-(2,6-dicloro-3,5-dimetoxifenil)-1-{6-[4-(4-etilpiperazin-1-il)-fenilamino]-pirimidin-4-il}-1-metilurea y sus sales
摘要 The present technology provides novel anhydrous and hydrated crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea, amorphous and anhydrous crystalline polymorphs of its monophosphoric acid salt, and the hydrochloride salt, including its dihydrate. The present technology further provides methods for preparing the various forms, compositions containing them, and methods of treatment employing them.
申请公布号 ES2562462(T3) 申请公布日期 2016.03.04
申请号 ES20100788479T 申请日期 2010.12.06
申请人 Novartis AG 发明人 BERGHAUSEN, Joerg;KAPA, Prasad Koteswara;MCKENNA, Joseph;SLADE, Joel;WU, Raeann;DU, Zhengming;STOWASSER, Frank
分类号 C07D239/48;A61K31/506;A61P35/00 主分类号 C07D239/48
代理机构 代理人
主权项
地址